DCT means it’s time to bring the technology to the data
Today’s clinical trials landscape is filled with point and unified solutions and the industry now needs to acknowledge that unified platforms cannot meet the challenges of implementing DCT. Whether it’s the pain around aggregating and integrating disparate data, the lack of speed in seeing that data or the two-dimensional and poor-quality visualizations, (charts, tables, and graphs really): all these challenges don’t give study teams the ability to take action and operationalize the data. So, what if we design our processes around what technology can do, rather than the other way around?
To run DCTs, teams ideally need a singular, holistic platform that encompasses the collection, review, management, analysis, and visualization of the trial data, however disparate that may be, utilizing a single build process. This ensures consistency across the data sources, inherent providence as well as efficient management of any protocol changes. During this webinar, from the perspective of a top 25 pharma use case, we’ll discuss how technology can offer the various involved teams, a holistic and real-time view of all the data in that trial, with visibility of trends across patients, sites, and possibly trials – and how all this can save you time and money.
Presented by
Temitope Keyes,
Executive Director, Business Development Technology at Cmed Technology
Temitope (Tope) Keyes brings 22 years of clinical R&D experience, which began on the sponsor side, with the majority of that primarily in the eClinical solutions space. She has a passion for technology and its ability to advance vital clinical research and successful trial execution. Her experience includes pre-clinical purchasing and clinical outsourcing roles at Astra-Zeneca and Sanofi, followed by almost 15 years in business development with the likes of ERT, Synteract, Datatrak, and Axiom Real-Time Metrics. Tope joined Cmed Technology in 2020 where she drives the sales and marketing for the encapsia clinical technology platform.
Mark Tomlinson,
Senior Director Technology Operations at Cmed Technology
Mark Tomlinson has over 30 years’ experience supporting the delivery of clinical trials, with two thirds of that focused on client delivery and adoption of technologies such as EDC and eSource. Mark is a firm believer in the benefit of true collaboration, where parties work together to meet client expectations and ensure achievement of the client’s tactical and strategic goals.
